EU Outlines New Rules On Releasing Drug Trial Data
Starting in January 2014, EMA plans to release clinical trial data on newly approved pharmaceutical drugs, which it claims will foster transparency and promote faster innovation. The agency noted that third-party stakeholders have been clamoring for additional clinical trial data disclosure as well as a more transparent regulatory decision-making process.
“Allowing external parties...
To view the full article, register now.